(S)-2-(3-Fluorophenyl)pyrrolidine d-tartrate, 97.0%, 10g

(4-iso-Propoxy-benzenesulfonyl)-acetonitrile, 98.0%, 1g

(2R,3S,5R)-5-(4-BENZAMIDO-2-OXOPYRIMIDIN-1(2H)-YL)-2-((BENZOYLOXY)METHYL)-4-METHYLENETETRAHYDROFURAN-3-YL BENZOATE, 98%, 25mg

(1-(3-Chlorophenyl)-1H-pyrazol-4-yl)boronic acid, 97%, 1g

4-(2,2-Diphenylethenyl)-N,N-di(p-tolyl)aniline>98.0%(HPLC)(N)5g

(4-Chloro-3-(4-ethoxybenzyl)phenyl)((3aS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)methanone, 97%, 10g

Segnali di obbligo secondo ISO 7010, Protezione respiratoria obbligatoria, 200 mm, 1 pezzo

spiro[2.5]octan-5-amine hydrochloride, 100mg

Tert-butyl (tetrahydro-2H-thiopyran-4-yl)carbamate, 98%, 1g

ethyl 8-bromo-4-oxo-6-(trifluoromethoxy)-1,4-dihydroquinoline-3-carboxylate, 98%, 1g

Sodium 4-(3-(4-hydroxyphenyl)-1,1-dioxido-3H-benzo[c][1,2]oxathiol-3-yl)phenolate, 95.0%, 100g

(1R)-((2S,4S,5R)-5-Ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methanol, 95.0%, 10g

3-G1F 2AB (500pmol/vial)>95.0%(HPLC)1vial